US EditionPfizer Sues to Stop Rival Bid for Drugmaker Metsera by Denmark’s Novo Nordisk
16 Articles
16 Articles
The opa war between Pfizer and Novo Nordisk over the US start-up Metsera, which specializes in popular treatments against obesity, points to a strong judicial dispute, at least for the time being, awaiting possible improvements in the offers of those concerned. In just over 72 hours, Pfizer has filed two complaints against Metsera and the Danish manufacturer of Wegovy and Ozempic, before the courts of the United States. Continue reading
Pfizer Sues Novo, Metsera for Second Time in Brewing Deal War
Pfizer Inc. accused Novo Nordisk A/S of trying to stifle competition in the weight-loss market by attempting to acquire obesity startup Metsera Inc., the second lawsuit in four days as Pfizer tries to retain its grip on a deal that Novo upended last week.
Pfizer accuses Novo Nordisk of violating competition rules in connection with a bid for Metsera.
Coverage Details
Bias Distribution
- 50% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
